Forget about wearing your Apple Watch to track your health. Levels is the biowearable that provides real-time feedback on how your diet and activities directly impact your health. Through continuous glucose monitoring, which has traditionally been reserved for those with diabetes, the company is on a mission to address the rising rates of metabolic dysfunction in the US by monitoring the effects of your food choices. Levels currently has a waitlist of 44,000 people. AlleyWatch caught up with founders Casey Means MD Josh Clemente, Sam Corcos, David Flinner and Andrew Conner to discuss the importance of metabolic health, the company’s plans to expand the team across engineering, operations, and marketing, and recent funding round from investors that include A16z, Marc Randolph, Dick Costolo, Michael Arrington, and Matt Dellavedova.